Regencell Bioscience Holdings Limited (RGC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.44
+10.06%
Mkt Cap $3.80B
No analyst coverage available
We don't have analyst ratings or price target data for Regencell Bioscience Holdings Limited yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.